Neurodevelopmental Outcomes at 1 Year in Infants of Mothers Who Tested Positive for SARS-CoV-2 During Pregnancy

Andrea G Edlow1, Victor M Castro2,3, Lydia L Shook1

  • 1Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston.

JAMA Network Open
|June 9, 2022
PubMed

Insights

Maternal SARS-CoV-2 infection during pregnancy may increase the risk of neurodevelopmental disorders in infants. Further research is needed to confirm these findings and understand long-term effects.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatrics
  • Infectious Diseases

Background:

  • Maternal immune activation in pregnancy is linked to offspring neurodevelopmental issues.
  • The impact of SARS-CoV-2 infection in utero on infant neurodevelopment requires investigation.

Purpose of the Study:

  • To determine if in utero SARS-CoV-2 exposure is associated with neurodevelopmental disorders in infants within the first year of life.

Main Methods:

  • Retrospective cohort study of live births from March to September 2020.
  • Maternal SARS-CoV-2 infection confirmed via PCR testing during pregnancy.
  • Neurodevelopmental disorders identified using ICD-10 codes from electronic health records.

Main Results:

  • The study included 7772 live births, with 222 from mothers infected with SARS-CoV-2.
  • Maternal SARS-CoV-2 infection was associated with a higher rate of neurodevelopmental diagnoses in offspring (adjusted OR, 1.86).
  • Third-trimester infection showed a stronger association (adjusted OR, 2.34).

Conclusions:

  • Preliminary evidence suggests a potential association between maternal SARS-CoV-2 infection in utero and infant neurodevelopmental sequelae.
  • Prospective studies with extended follow-up are necessary to confirm these findings and rule out confounding factors.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K